HCID 178440298, compound → HCID 178440299, compound
Reaction equation
[CH3:1][C:2]1[NH:3][C:4]2[N:5]([N:7]=[C:8]([CH2:47][CH2:48][CH3:49])[C:9]=2[CH2:10][C:11]2[CH:16]=[CH:15][C:14]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[C:23]3[N:27](C(C4C=CC=CC=4)(C4C=CC=CC=4)C4C=CC=CC=4)[N:26]=[N:25][N:24]=3)=[CH:13][CH:12]=2)[N:6]=1>C(OCC)(=O)C>[CH3:1][C:2]1[NH:3][C:4]2[N:5]([N:7]=[C:8]([CH2:47][CH2:48][CH3:49])[C:9]=2[CH2:10][C:11]2[CH:12]=[CH:13][C:14]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[C:23]3[NH:24][N:25]=[N:26][N:27]=3)=[CH:15][CH:16]=2)[N:6]=1Participants
3
Reagents, catalysts & solvents 1
Procedure
A 183 mg portion of 2-methyl-6-propyl-7-[[2'-(N-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-pyrazolo[1,5-b][1,2,4]triazole (compound 1c) was treated in the same manner as described in Example 12, the resulting residue was dissolved in ethyl acetate with heating and then the solution was cooled to collect the thus formed precipitate by filtration, thereby giving 85 mg of 2-methyl-6-propyl-7-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1 H-pyrazolo[1,5-b][1,2,4]triazole in the form of colorless amorphous solid.
Workup
- temperaturewith heating
- temperaturethe solution was cooled
- customto collect the thus formed precipitate
- filtrationby filtration
Sources & evidence
- ORD record
- ord-4340d29a268c4706b2f2851066f2b021
- Source dataset
- uspto-grants-1995_12
- Patent number
- US05475114
Reaction notes
Loading…